Canadian Pharmacists Association: Transforming Primary Care in Canada Summit 2024: White paper.

IF 1.6 Q3 PHARMACOLOGY & PHARMACY Canadian Pharmacists Journal Pub Date : 2024-10-12 DOI:10.1177/17151635241285920
Shania Liu, Danielle Paes, Yazid N Al Hamarneh, Ross T Tsuyuki
{"title":"Canadian Pharmacists Association: Transforming Primary Care in Canada Summit 2024: White paper.","authors":"Shania Liu, Danielle Paes, Yazid N Al Hamarneh, Ross T Tsuyuki","doi":"10.1177/17151635241285920","DOIUrl":null,"url":null,"abstract":"","PeriodicalId":46612,"journal":{"name":"Canadian Pharmacists Journal","volume":" ","pages":"17151635241285920"},"PeriodicalIF":1.6000,"publicationDate":"2024-10-12","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11556639/pdf/","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Canadian Pharmacists Journal","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1177/17151635241285920","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q3","JCRName":"PHARMACOLOGY & PHARMACY","Score":null,"Total":0}
引用次数: 0
查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
加拿大药剂师协会:2024 年加拿大初级保健转型峰会:白皮书。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 去求助
来源期刊
Canadian Pharmacists Journal
Canadian Pharmacists Journal PHARMACOLOGY & PHARMACY-
CiteScore
2.50
自引率
26.70%
发文量
43
期刊介绍: Established in 1868, the Canadian Pharmacists Journal is the oldest continuously published periodical in Canada. Our mission is to enhance patient care through advancement of pharmacy practice, with continuing professional development, peer-reviewed research, and advocacy. Our vision is to become the foremost journal for pharmacy practice and research.
期刊最新文献
The role of Alberta pharmacists working in opioid use disorder and their potential to prescribe buprenorphine-naloxone: A qualitative study. Opportunities and challenges associated with the launch of nirmatrelvir/ritonavir (Paxlovid) in British Columbia during the COVID-19 pandemic: A qualitative study to explore community pharmacists' perspectives. Lyme disease chemoprophylaxis prescribing before and after pharmacist prescriptive authority in Nova Scotia. Enabling pharmacist prescribing: Lessons learned in Nova Scotia using behaviour change theory. British Columbia community pharmacy during COVID-19: Describing the patient experience via Google reviews.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1